DOW Surges Over 500 Points, GSK CEO & Bioreference CEO

episode

Mad Money w/ Jim Cramer not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

The Songs of John Farnham: A Living Legend | Tony Cochrane (23.09.26) 7 min · 23 Sep 2026 · Whateley

Las 10 de Erazno, el Chokolatazo, Parodias, 1h 29m · 23 Sep 2026 · Erazno y La Chokolata El Podcast

Steve Hilton & Spencer Pratt: Fixing California, Cheaper Gas, Ballot Fraud & CA Republicans 55 min · 23 Sep 2026 · All-In with Chamath, Jason, Sacks & Friedberg

Optics of Alastair Clarkson's brunt sacking | The Eminently Sensible Phil Davis (23.09.26) 1 min · 23 Sep 2026 · Whateley

The Eminently Sensible Phil Davis | Whateley (23.09.26) 13 min · 23 Sep 2026 · Whateley

The impact of Zak Butters' homecoming | The Eminently Sensible Phil Davis (23.09.26) 1 min · 23 Sep 2026 · Whateley

Report any issue

Source

Recorded14 Apr 2020

Publisherfeeds.simplecast.com ↗

Handlerec:4817310

Show notes

The market rallied today and Cramer is diving into the coronavirus developments and the impact on business. Then, an exclusive interview with GSK CEO, Emma Walmsley, on the announcement of the company’s historic collaboration with Sanofi to develop and produce a vaccine for COVID-19. And, Cramer goes off the carts to examine how the pandemic is affecting the defense industry. Plus, Dr. Jon Cohen, executive chairman of BioReference Laboratories, joins the program to discuss the state of drive-thru testing in New York and New Jersey and what it means for mass testing roll outs across the country. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in